COPD: Definition and phenotypes

Clinics in Chest Medicine

Volumn 35, Issue 1, 2014, Pages 1-6

  Vestbo, Jørgen ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Chronic inflammation; COPD; Definition; Diagnosis; Lung function

Indexed keywords

CHRONIC INFLAMMATION; COPD; DEFINITION; DIAGNOSIS; LUNG FUNCTION;

HUMANS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84893784355     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2013.10.010     Document Type: Review

References (25)

1. Snider G.L. Definition of chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease 2003, 1-10. Arnold, London. 2nd edition. P.M. Calverley, W. MacNee, N.B. Pride (Eds.).
2. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995, 152:S77-S121.
3. Siafakas N.M., Vermeire P., Pride N.B., et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995, 8:1398-1420.
4. Pauwels R.A., Buist A.S., Calverley P.M., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001, 163:1256-1276.
5. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med 2007, 176(6):532-555.
6. Vestbo J., Hurd S.S., Agusti A.G., et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med 2013, 187:347-365.
7. Available at: Accessed May 2, 2013. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf.
8. Ulrik C.S., Løkke A., Dahl R., et al. Early detection of COPD in general practice. Int J Chron Obstruct Pulmon Dis 2011, 6:123-127.
9. Pellegrino R., Brusasco V., Viegi G., et al. Definition of COPD: based on evidence or opinion?. Eur Respir J 2008, 31:681-682.
10. Vollmer W.M., Gislason T., Burney P., et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009, 34:588-597.
11. Bakke P.S., Rönmark E., Eagan T., et al. Recommendations for epidemiological studies on COPD. ERS Task Force Report. Eur Respir J 2011, 38:1261-1277.
12. McMurray J.J., Adamopoulos S., Anker S.D., et al. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012, 33:1787-1847.
13. Han M.K., Agusti A., Calverley P.M., et al. COPD phenotypes: the future of COPD. Am J Respir Crit Care Med 2010, 182:598-604.
14. Snider G. Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology. Am Rev Respir Dis 1989, 140(3 Pt 2):S3-S8.
15. Lötvall J., Akdis C.A., Bacharier L.B., et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. JAllergy Clin Immunol 2011, 127:355-360.
16. Airways responsiveness and atopy in the development of chronic lung disease 1989, Raven Press, New York. T.W. Scott, D. Sparrow (Eds.).
17. Albert P.S., Agusti A., Edwards L.D., et al. Bronchodilator responsiveness is not a consistent phenotypic characteristic of COPD. Thorax 2012, 67:701-708.
18. Vestbo J., Edwards L.D., Scanlon P.D., for the ECLIPSE Investigators, et al. Change in forced expiratory volume in 1 second over time in COPD. NEngl J Med 2011, 365:1184-1192.
19. Guerra S., Sherrill D.L., Venker C., et al. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax 2009, 64:894-900.
20. Hurst J.R., Vestbo J., Anzueto A., for the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. NEngl J Med 2010, 363:1128-1138.
21. Soler-Cataluña J.J., Martínez-García M.A., Román Sánchez P., et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005, 60:925-931.
22. Celli B.R., Thomas N.E., Anderson J.A., et al. Effect of pharmacotherapy on rate of decline of lung function in COPD: results from the TORCH study. Am J Respir Crit Care Med 2008, 178:332-338.
23. Celli B.R., Locantore N., Yates J., for the ECLIPSE investigators, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012, 185:1065-1072.
24. Agusti A., Edwards L.D., Rennard S.I., for the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012, 7:e37483.
25. Thomsen M., Dahl M., Lange P., et al. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012, 186:982-988.